Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Búsqueda de investigadores y pymes para la convocatoria H2020 SFS-14-2016 (Entendiendo interacciones entre portadores, patógenos y medioambiente)

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDUK20151218001
Publicado:
11/02/2016
Caducidad:
18/12/2016
Resumen:
Un centro de investigación británico especializado en salud pública busca investigadores con el fin de presentar una propuesta a la convocatoria H2020 SFS-14-2016. El proyecto se centra en la gripe animal y tiene como objetivo investigar la transmisibilidad de la dinámica entre especies. Se buscan pymes y centros de investigación con experiencia en gripe animal, vacunas, nuevos agentes terapéuticos contra la gripe, modelos animales de gripe aviar u otras cepas de gripe zoonótica, y descubrimiento/desarrollo de vacunas. El plazo para presentar expresiones de interés finaliza el 18 de enero de 2016.

Details

Tittle:
URGENT - Research and SME partners sought for H2020 SFS-14-2016 Understanding host-pathogen-environment interactions
Summary:
UK research organisation specialising in public health seeks research partners for H2020 SFS-14-2016 call. The project focus is animal influenza, investigating the dynamics transmissibility between species. Partners sought are SME and research institutions with active research/expertise in animal influenza, vaccines and novel therapeutics active against influenza, also capabilities in animal models of avian influenza or other zoonotic influenza strains, vaccine discovery/development.
Description:
The organisation focuses on public health research and encourages discussions, advises government and supports action by local government, the National Health Service and other organisations. They are actively engaged in applied research in microbiology and working across a range of aspects of microbial translational research, from vaccine candidate discovery and evaluation to developing and testing diagnostics and other interventions against infectious diseases and across healthcare and public health. In vaccine evaluation, they are active in developing in vitro evaluation assays, provide immunological measurement of a range of responses from in-vivo models and clinical samples, carry out potency and efficacy studies using a range of specific challenge models, have the most extensive infectious disease modelling capability in the UK with facilities at bio-containment levels 2-4 and provide access to clinical trial centres for onward development. In addition, they have access to an extensive range of authenticated viruses, bacteria, fungi and cell cultures for use as control strains and to support a wide range of biomedical research projects such as disease modelling, drug development, cancer research and vaccine studies. The institution has state of the art facilities for producing and inactivating vaccine antigens as well as for assessing pre-clinical vaccine efficacy, and access to a large collection of authenticated viral strains.

They are seeking partners from other research organisations and SMEs with all aspects of active research on avian and/or other animal influenza to join consortia to investigate the transmissibility of the disease in line with Horizon 2020 topic SFS-14-2016 project ´Understanding host-pathogen-environment interactions´. The project is focused on avian, (H5 -Y- H7) influenza strains and aims to investigate vector interactions and transmission between different agricultural species. This is considered highly relevant and timely given the recent H5 transmissions between farms in the USA. Investigation into avian influenza vector interactions and transmission between different agricultural species will also be required through the project as will assessing a novel zero time response system against highly pathogenic influenza.

The research activities carried out by interested organisations can be diverse as they in the early stages of forming consortia and would be open to negotiating the scope of the project to ensure that all consortium partners are represented. They would like influenza infections which affect animal health to be the area of focus for any new consortia members. Potential partners with research expertise in vaccines and novel therapeutics active against influenza would be particularly welcome, especially those with expertise in universal influenza vaccines. Partners with capabilities in animal models of Avian influenza or other zoonotic influenza strains, vaccine discovery -Y- development and those with European surveillance programmes would be welcomed.

Consortia is currently being formed alongside a group of highly experienced research institutions from Eastern Europe and they are negotiating the participation of one other national non-EU research institution (the latter institution is also eligible to receive Horizon 2020 funding). All of these institutions represent national experts in avian influenza in their respective countries. The institution also has significant experience in previous FP7, H2020 and other EU funding streams.

The deadline for the stage 1 of the two-stage call is 17th February 2016 and the deadline for expressions of interest from interested institutions should be made no later than by Monday 18th January 2016. The deadline for the second stage of the call is 13th September 2016 and the project is expected to start in Q1/Q2 2017.
Advantages and Innovations:
The research organisation is actively engaged in research in microbiology and has state of the art facilities for producing and inactivating vaccine antigens as well as for assessing pre-clinical vaccine efficacy, also with access to a large collection of authenticated viral strains.
They have significant experience in previous FP7, H2020 and other EU funding streams.
In addition to investigating avian influenza vector interactions and transmission between different agricultural species they will also be assessing a novel zero time response system against highly pathogenic influenza.
Stage of Development:
Proposal under development

Partner sought

Partner Sought:
Research institutions, academia, industrial partners and SMEs from EU and other eligible countries are sought. The research activities carried out by interested organisations can be diverse as the UK organisation is in the early stages of forming consortia and would be open to negotiating the scope of the project to ensure that all consortium partners are represented. They would like influenza infections which affect animal health to be the area of focus for any new consortia members. Potential partners with research expertise in vaccines and novel therapeutics active against influenza would be particularly welcome, especially those with expertise in universal influenza vaccines. Partners with capabilities in animal models of avian influenza or other zoonotic influenza strains, vaccine discovery -Y- development and those with European surveillance programmes would be welcomed.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
Other
Already Engaged in Trans-National Cooperation:
Si

Dissemination

Programme-call

Anticipated Project Budget:
Between £5m - £5.5m
Coordinator Required:
No
Deadline for Call:
17/02/2016
Project Duration:
0